Israel’s MigVax Receives $4.3M Award For Development Of Oral Vaccine
The funding is part of a $200 million CEPI program to advance the development of vaccines that provide protection against COVID-19 variants.
November 07, 2021
Israeli Oral COVID-19 Vaccine Set To Begin Clinical Trials In South Africa
The oral COVID-19 vaccine developed by Israel's Oramed Pharmaceuticals will be taken by 24 unvaccinated volunteers this month.
November 02, 2021
Israeli Oral COVID-19 Vaccine Booster Found Effective In Preclinical Trials
MigVax is ready to begin human clinical trials with its oral vaccine and is on track to market it as a booster in the next year.
June 15, 2021